Skip to content

PHARMA PLUS

Active Private limited companyfounded 1987active for 38 yearsRue Alfred Dendal 192, 7300 BoussuKBO/BCE: BE 0432.850.028 subsidiary of #4 company by equity in Boussu, Wholesale and retail trade sector
Part of the group 42 companies

Lifetime

20 annual accounts with figures on one time axis, 38 filings since 1988
peak of €627,611 in 2016
€248,353▼ 58.8%
lowest -€29,963 in 2020
€15,884▼ 79.7%
peak of €1.1m in 2022
€876,038▲ 1.8%
€152,303▼ 19.5%
peak of 6.5 FTE in 2017
4.1 FTE▼ 2.4%
Board8 names since 2011
3 directors and 2 others
Owners2 names in the annual accounts
100%
Documentsfilings and deeds
12-05-202680 days before the deadline
2025financial year
Gross margin from €602,949 to €248,353Result from €78,352 to €15,884Debts from €189,118 to €152,303Investments €23,626

Key points

from the 2025 annual accounts

Equity

€876,038 ▲ 1.8%

PHARMA PLUS has made a profit without a break since 2021.

Result

€15,884 ▼ 79.7%
€78,4002024€15,9002025

The result fell in 2025: the 2024 profit included a one-off income of €350,000.

Investments

€23,626 2.0 times depreciation
20212022202320242025

Green is investment, beige is depreciation.

Staff

4.1 FTE from 6.5 in 2017

Between 2017 and 2025, 37% of the full-time equivalents disappeared.

Filings

38 annual accounts since 1988
AprilJune31 JulyOctober1990200020102020

The last five annual accounts were filed 44 to 80 days before the end of the period.

Position in the sector

85.2%

Higher solvency than 94% of companies in retail trade. Sector median 33.4% · 2,455 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 17,047 companies had the same profile as PHARMA PLUS has now. Each dot stands for 43 companies, two years later.

94.3%
were still trading
5.0%
stopped another way
0.5%
went bankrupt
  • Micro
  • 20 years or older
  • solvency 30% or more
  • a profit under 5% of the balance sheet

Another 0.2% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 17,047 companies, not a prediction for PHARMA PLUS. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Chair,
Managing director,
Managing director
Director,
  • 100%score equity €33.0m (2025) · annual accounts 2025 of
Board & ownership

Recent changes

1 director appointed, 1 resignation, 1 reappointment resigns · appointed · acts as permanent representative · General meeting of 19-05-2026 · Gazette deed
Registered in the Peppol Directory Reachable for e-invoices through 0208:0432850028
New chair of the board appointed, resigned · and act as permanent representatives · Board meeting of 01-09-2022 · Gazette deed
1 director appointed, 1 resignation Issue of 17,000 shares · changes role from director to managing director · appointed as chair · General meeting of 22-12-2020 · Gazette deed
All 55 events

Comparable companies

same main activity, similar in size and age
Company
PHARMA PLUS Boussu €1.0m €248,353 85.2% 4.1
APOTHEEK DE PAUW - VARSENARE Jabbeke €1.0m €294,313 66.7% 3.7
Pharmacie des Citronniers Brussels €0.9m €270,611 10.3% 4.4
Pharmacie De Spiegeleere-Roosendael Forest €1.0m €292,684 35.3% 4.6
PHARDUP Etterbeek €0.8m €269,027 22.7% 4
ANCIAUX Woluwe-Saint-Pierre €0.8m €276,427 12.8% 3.9
PHARMADUO Ottignies-Louvain-la-Neuve €1.0m €323,380 36.6% 3.8

These companies have the same main activity as PHARMA PLUS: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €818,000 and €1m, founded between 1982 and 1989.

Official details

Source: KBO
Status
Active since 21-12-1987Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Joint committee
313Pharmacies and pricing offices · annual accounts 2025
Establishment unit
2.034.066.5417300 Boussu, since 02-02-1988
Financial year end
31 December
Peppol
Reachable since 06-06-2025
Company details

Annual accounts 2025

≈ €1.2mestimated
€1.0m▼ 2.0%
Employeeson 31-12-2025
5=
Filing
Filed on 12-05-2026, 80 days before the end of the filing period
Financials

Companies linked to PHARMA PLUS

Parent and group

Insights on PHARMA PLUS

PHARMA PLUS has existed since 1987. The gross margin fell from €602,949 in 2024 to €248,353 in 2025.

holds all the shares.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about PHARMA PLUS

What is the company number of PHARMA PLUS?
The company number of PHARMA PLUS is 0432.850.028. The VAT number is the same number with BE in front: BE 0432.850.028.
Where is PHARMA PLUS based?
The registered office is at Rue Alfred Dendal 192, 7300 Boussu.Company details
What does PHARMA PLUS do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of PHARMA PLUS?
PHARMA PLUS is a private limited company (BV).
When was PHARMA PLUS founded?
PHARMA PLUS was founded on 21-12-1987.
Is PHARMA PLUS still active?
Yes, PHARMA PLUS is an active enterprise in the KBO register.
How many employees does PHARMA PLUS have?
PHARMA PLUS had an average of 4.1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does PHARMA PLUS fall under?
In its 2025 annual accounts, PHARMA PLUS states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of PHARMA PLUS?
The turnover in financial year 2025 is ≈ €1.2m. This figure is estimated from the gross margin of €248,353 and 43 comparable companies (NACE 477). It probably lies between €760,000 and €2.5m.
Is PHARMA PLUS profitable?
In financial year 2025, PHARMA PLUS made a profit of €15,884.
Where can I find the annual accounts of PHARMA PLUS?
PHARMA PLUS filed 38 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of PHARMA PLUS due?
PHARMA PLUS must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.